rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-2-9
|
pubmed:abstractText |
Inhaled bronchodilators are first line drugs in the treatment of chronic obstructive pulmonary disease (COPD). Tiotropium bromide is a recently introduced long-acting anticholinergic agent able to reduce dyspnoea and COPD exacerbations and to improve pulmonary function and quality of life. We designed a study to compare the short-term efficacy of tiotropium bromide with that of oxitropium bromide in improving pulmonary function in patients with COPD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0954-6111
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
476-80
|
pubmed:meshHeading |
pubmed-meshheading:16919926-Aged,
pubmed-meshheading:16919926-Bronchodilator Agents,
pubmed-meshheading:16919926-Cholinergic Antagonists,
pubmed-meshheading:16919926-Female,
pubmed-meshheading:16919926-Humans,
pubmed-meshheading:16919926-Lung,
pubmed-meshheading:16919926-Male,
pubmed-meshheading:16919926-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:16919926-Respiratory Function Tests,
pubmed-meshheading:16919926-Scopolamine Derivatives
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
|
pubmed:affiliation |
Unit of Pulmonary Rehabilitation, ICP Hospital, via Bignami 1, Viale Molise 69, Milan, Italy. cristoforo.incorvaia@fastwebnet.it
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|